New SPECT/CT Scanner to Help Providers Transition Away from SPECT-Only Systems
|
By MedImaging International staff writers Posted on 14 Jun 2022 |

Historically, single photon emission computed tomography/computed tomography (SPECT/CT) has not been accessible to all healthcare providers. Instead, many institutions continue to use SPECT-only gamma cameras, which cannot always accommodate the clinical needs of a modern molecular-imaging or radiology department. Now, a new SPECT/CT scanner with its optimized, low-dose imaging, intuitive workflow, and ability to fit into most existing SPECT rooms removes barriers to SPECT/CT adoption and helps providers to transition from SPECT-only and early-generation SPECT/CT systems.
Siemens Healthineers (Erlangen, Germany) has launched Symbia Pro.specta, a SPECT/CT system with CE mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging technologies. Capabilities include a low-dose CT of up to 64 slices for impressive detail, automatic SPECT motion correction for additional image clarity, and an intuitive and automated workflow to guide the user through the entire decision-making process of the examination. Symbia Pro.specta is an all-purpose system that can be customized to accommodate a wide range of clinical exams, patient types, and department settings.
At the heart of Symbia Pro.specta is myExam Companion, which includes an intuitive user interface that eliminates the traditional manual and user-dependent SPECT/CT imaging workflow. myExam Companion provides automated tools to guide the user through every step of the exam’s decision-making process - from system and patient preparation to image acquisition and reconstruction to evaluation and post-processing. This enables departments to achieve consistent results quickly and more easily, regardless of the patient, procedure, or user experience level. Another major innovation that comes as standard is data-driven patient motion correction, which automatically corrects for patient movement in a SPECT exam with the click of a button, improving image quality without adding complexity. Additionally, data-driven respiratory motion correction for cardiac examinations is available as an option.
Designed for all SPECT/CT imaging applications, Symbia Pro.specta can be tailored as needed with specialized clinical tools for optimized imaging in cardiology, neurology, oncology, orthopedics, and more. Flexible detectors along with an accessible design facilitate imaging for a wide range of patient types - including pediatric, obese, and physically challenged patients - without compromising exam quality, patient comfort, or staff efficiency. The scanner also can be used for either stand-alone diagnostic CT or SPECT imaging, providing the user with the same intuitive interface for simpler operation.
Symbia Pro.specta features a minimum of 32 and a maximum of 64 CT slices, and it comes standard with a tin filter and CT iterative reconstruction for ultra-low patient and room dose. Its advanced quantification capabilities help the user determine the patient’s response to therapy. Capable of imaging at any energy level, the scanner is primed for imaging the high-energy isotopes increasingly used in theranostics, an approach that combines diagnostic and therapeutic agents to treat patients.
“Siemens Healthineers is proud to introduce the Symbia Pro.specta SPECT/CT scanner, which provides our customers with the ideal vehicle for transitioning from their SPECT-only and first-generation SPECT/CT cameras to a state-of-the-art SPECT/CT scanner that can perform a full spectrum of nuclear medicine examinations,” said Jim Williams, PhD, Head of Siemens Healthineers Molecular Imaging. “Symbia Pro.specta will help healthcare institutions overcome barriers to care by ensuring accessibility through its ease of use and ability to fit into existing SPECT rooms.”
Related Links:
Siemens Healthineers
Latest General/Advanced Imaging News
- AI Tool Predicts Side Effects from Lung Cancer Treatment
- AI Tool Offers Prognosis for Patients with Head and Neck Cancer
- New 3D Imaging System Addresses MRI, CT and Ultrasound Limitations
- AI-Based Tool Predicts Future Cardiovascular Events in Angina Patients
- AI-Based Tool Accelerates Detection of Kidney Cancer
- New Algorithm Dramatically Speeds Up Stroke Detection Scans
- 3D Scanning Approach Enables Ultra-Precise Brain Surgery
- AI Tool Improves Medical Imaging Process by 90%
- New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
- AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
- Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities
- Extending CT Imaging Detects Hidden Blood Clots in Stroke Patients
- Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans
- New CT-Based Indicator Helps Predict Life-Threatening Postpartum Bleeding Cases
- CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
- First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Channels
Radiography
view channel
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read more
AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
Breast cancer screening saves lives but still relies largely on uniform schedules despite wide differences in individual risk. This one-size-fits-all approach can miss cancers in higher-risk women while... Read moreMRI
view channel
Ultra-Detailed Brain Atlas Enhances Early Detection of Neurological Disorders
Precise localization of small and deep brain structures remains a hurdle for radiology and neurosurgical planning. Limited resolution in many magnetic resonance imaging atlases constrains segmentation... Read more
Study Finds Advanced Imaging Significantly Reduces Unnecessary Prostate Biopsies
Many men with suspected prostate cancer face an invasive biopsy when magnetic resonance imaging (MRI) is inconclusive. Biopsies can be uncomfortable, carry risks, and may contribute to overdiagnosis and... Read moreUltrasound
view channel
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read more
Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
Rapid and accurate imaging is essential for diagnosing life-threatening conditions such as myocardial infarction, heart failure, and pulmonary embolism. However, conventional ultrasound imaging of the... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







